This year’s Rallying to the Challenge will be held virtually. The program was developed in collaboration with Team Spark. Please note, all times are in the Eastern time zone.
PRELIMINARY VIRTUAL PROGRAM
The following program is being finalized and is subject to change. Times will be added in the coming weeks.
THURSDAY, SEPT. 24, 2020
Welcome and opening comments
When and how does Parkinson’s start? — The science
Simon Stott, Ph.D. — Deputy Director of Research at The Cure Parkinson’s Trust; Science of Parkinson’s
When and how does Parkinson’s start? — The lived experience
Survey findings presented by Team Spark
Stretch and move
Davis Phinney
What is prodromal Parkinson’s?: Why might identifying prodromal Parkinson’s be important? Is it possible to delay development/progression of prodromal Parkinson’s?
Ron Postuma, M.D. — McGill University (including Q&A) (to be confirmed)
Stretch and move
Davis Phinney
What role might the gut play?
Viviane Labrie, Ph.D., Per Borghammer, M.D., Ph.D., D.MSc., and Richelle Flanaghan
Does insulin resistance/diabetes make a difference?
Dilan Athauda, MBBS, MRCP, B.Sc.; Tom Foltynie, Ph.D., M.D., MRCP; Rachel Gibson, Ph.D.
Live panel and Q&A
Guided discussion
Moderated by Kevin McFarthing, Ph.D.
Could viruses influence Parkinson’s?
David Beckham, M.D.
The immune system in early PD
Dave Sulzer, Ph.D. (to be confirmed)
Your questions answered – COVID-19 and PD
Virtual glass of wine (virtual happy hour)
FRIDAY, SEPT. 25, 2020
Welcome and opening remarks
What are the genetic risk factors for PD?
Ben Stecher and Ziv Gan-Or, M.D., Ph.D.
How could the environment be involved?
Alison Bernstein, Ph.D.
Stretch and move
Davis Phinney
PD Avengers introduce the PACT – what does it mean?
Larry Gifford, Tim Hague, Soania Mathur, M.D., Hugh Johnson
Caring to curing: A simple letter change – feedback from the Linked Clinical Trials meeting
Q&A with Simon Stott, Ph.D., Richard Wyse, M.D., Patrik Brundin, M.D., Ph.D.
Presentation of the Tom Isaacs Award
Report from Rallying to the Challenge